SCIENTIFIC COMMUNIQUÉ XI: Developing Novel Treatments for Arterial Ischaemic Stroke Patients 2021 Announcements.Newsletter.Stories 10.08.2021
Afamelanotide well tolerated by first stroke patients 2021 Announcements . Clinical . News 10.08.2021
Insider Insights III: Willem Blijdorp – Challenges & the Future 2021 Announcements . Corporate . News . Presentation . Stories 14.07.2021
Insider Insights II: Willem Blijdorp – CLINUVEL’s Products, People & Social Purpose 2021 Announcements . Corporate . News . Presentation . Stories 07.07.2021
Insider Insights: Willem Blijdorp – Chair of The CLINUVEL Group 2021 Announcements . Corporate . News . Presentation . Stories 30.06.2021
Media Release – First stroke patient treated with afamelanotide 2021 Announcements . Clinical . News 07.06.2021